Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone plus butorphanol for analgesia in ICU postpartum patients
ChiCTR2200061745Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain and Postpartum pain (PPP) comparing Hydromorphone + butorphanol with Butorphanol alone (2 arms). Primary endpoint: Proportion of patients achieving target analgesia at all time points. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
hydromorphonebutorphanol
03
Conditions
postoperative painPostpartum pain (PPP)
Beyond the preview
Go deeper on ChiCTR2200061745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061745.